Aktuellt
SENASTE
Redeye comments on Gasporox's Q4 report, which was in line with estimates. The quarter’s highlights were substantial working capital releases, resulting in solid CFFO. Going into 2024, Redeye estimates Gasporox has an order book standing at SEK12.6m, about 36% of its 2024 estimate. Redeye expects to make minor adjustments to its estimates and fair value range following the report.
LÄS MER
